Markus Joerger
University of St.Gallen(CH)Kantonsspital St. Gallen(CH)Ostschweizer Fachhochschule OST(CH)Ostschweizer Kinderspital(CH)
Publications by Year
Research Areas
Cancer Treatment and Pharmacology, Lung Cancer Treatments and Mutations, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, PARP inhibition in cancer therapy
Most-Cited Works
- → Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps(2015)399 cited
- → SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial(2021)337 cited
- → Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy(2004)286 cited
- → Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study(2019)170 cited
- → Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer(2009)152 cited
- → Clinical importance of risk variants in the dihydropyrimidine dehydrogenase gene for the prediction of early‐onset fluoropyrimidine toxicity